PT UBC Medical Indonesia Tbk (IDX:LABS)
Indonesia · Delayed Price · Currency is IDR 149.00
0.00 (0.00%)
Apr 29, 2026, 9:15 AM WIB
IDX:LABS Revenue
In the year 2025, PT UBC Medical Indonesia Tbk had annual revenue of 199.30B IDR with 34.99% growth. PT UBC Medical Indonesia Tbk had revenue of 63.86B in the quarter ending December 31, 2025, with 54.97% growth.
Revenue
199.30B
Revenue Growth
+34.99%
P/S Ratio
2.95
Revenue / Employee
3.69B
Employees
54
Market Cap
588.55B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 199.30B | 51.66B | 34.99% |
| Dec 31, 2024 | 147.64B | 10.94B | 8.00% |
| Dec 31, 2023 | 136.70B | 43.41B | 46.53% |
| Dec 31, 2022 | 93.29B | -36.67B | -28.22% |
| Dec 31, 2021 | 129.96B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PT Kalbe Farma Tbk. | 35.32T |
| PT Siloam International Hospitals Tbk | 12.85T |
| PT Mitra Keluarga Karyasehat Tbk | 5.37T |
| PT. Penta Valent Tbk | 3.55T |
| PT Sejahteraraya Anugrahjaya Tbk | 2.59T |
| PT Itama Ranoraya Tbk | 1.10T |
| PT Ikapharmindo Putramas Tbk | 377.10B |
| PT Indofarma Tbk | 206.24B |